These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 15831200
21. Towards the use of nanoparticles in cancer therapy and imaging. Pauwels EK, Erba P. Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933 [Abstract] [Full Text] [Related]
22. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS, Ramakrishna S, Saini TR, Diwan PV. Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [Abstract] [Full Text] [Related]
23. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Huang ZR, Hua SC, Yang YL, Fang JY. Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178 [Abstract] [Full Text] [Related]
24. Drug delivery in cancer using liposomes. Dass CR. Methods Mol Biol; 2008 Sep; 437():177-82. PubMed ID: 18369969 [Abstract] [Full Text] [Related]
25. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. Manjunath K, Venkateswarlu V. J Control Release; 2005 Oct 03; 107(2):215-28. PubMed ID: 16014318 [Abstract] [Full Text] [Related]
26. Hyperthermia mediated liposomal drug delivery. Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW. Int J Hyperthermia; 2006 May 03; 22(3):205-13. PubMed ID: 16754340 [Abstract] [Full Text] [Related]
28. pH-responsive nanoparticles for cancer drug delivery. Shen Y, Tang H, Radosz M, Van Kirk E, Murdoch WJ. Methods Mol Biol; 2008 May 03; 437():183-216. PubMed ID: 18369970 [Abstract] [Full Text] [Related]
29. Solid lipid nanoparticles for targeted brain drug delivery. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Adv Drug Deliv Rev; 2007 Jul 10; 59(6):454-77. PubMed ID: 17570559 [Abstract] [Full Text] [Related]
30. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Gindy ME, Prud'homme RK. Expert Opin Drug Deliv; 2009 Aug 10; 6(8):865-78. PubMed ID: 19637974 [Abstract] [Full Text] [Related]
32. Approaches for the development of solid and semi-solid lipid-based formulations. Jannin V, Musakhanian J, Marchaud D. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):734-46. PubMed ID: 18045728 [Abstract] [Full Text] [Related]
33. Active targeting schemes for nanoparticle systems in cancer therapeutics. Byrne JD, Betancourt T, Brannon-Peppas L. Adv Drug Deliv Rev; 2008 Dec 14; 60(15):1615-26. PubMed ID: 18840489 [Abstract] [Full Text] [Related]
34. Nanoparticles for drug delivery in cancer treatment. Haley B, Frenkel E. Urol Oncol; 2008 Dec 14; 26(1):57-64. PubMed ID: 18190833 [Abstract] [Full Text] [Related]
35. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Int J Pharm; 2007 Jan 10; 328(2):191-5. PubMed ID: 16978810 [Abstract] [Full Text] [Related]
36. Ligand-based targeted therapy for cancer tissue. Das M, Mohanty C, Sahoo SK. Expert Opin Drug Deliv; 2009 Mar 10; 6(3):285-304. PubMed ID: 19327045 [Abstract] [Full Text] [Related]